No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
Beijing Tongrentang Co., Ltd engages in the production and sale of traditional Chinese medicine preparations in China and internationally. The company offers various product dosage forms, such as pills, powders, medicated wines, capsules, oral liquids, and drop pills. Its products are used for cardiovascular, cerebrovascular, gynecology, heat-clearing, respiratory system, nourishing and calming, digestive, pediatrics, wind-dispelling and dampness removing, orthopedics, facial features, dermatological surgery, mental health, and food and beverages applications. The company was founded in 1997 and is based in Beijing, China. Beijing Tongrentang Co., Ltd operates as a subsidiary of China Beijing Tong Ren Tang Group Co. Ltd.
gf.tongrentang.comNo one on the platform currently holds 600085.SS.
No tracked institution reports a position in 600085.SS as of their last filing.
No one on the platform has traded 600085.SS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 28.1% | 49.0% | 46.2% | — | — | — |
| Rev. Growth % | -7.2% | 6.1% | ||||
| Profit Margin % | 6.9% | 8.4% | 8.1% | |||
| Free Cash Flow Margin % | 13.5% | 12.3% | 10.0% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $17.6B | -4.5% | $0.91 | $0.82–$0.97 | — | 2 |
| 2027 | $19.1B | +8.1% | $1.00 | $0.96–$1.04 | — | 3 |
| 2028 | $20.5B | +7.3% | $1.25 | $1.19–$1.32 | — | 3 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-31 | $0.28 | $0.19 | -32.1% |
| 2026-04-27 | $0.37 | $0.34 | -7.0% |
| 2026-03-30 | $0.31 | $0.31 | +0.0% |
| 2025-10-28 | $0.27 | $0.17 | -36.2% |
| 2025-08-29 | $0.35 | $0.26 | -24.3% |
| 2025-04-29 | $0.38 | $0.43 | +13.2% |
| 2024-12-31 | $0.18 | $0.13 | -30.5% |
| 2024-10-29 | $0.30 | $0.24 | -20.0% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 600085.SSBeijing Tongrentang Co., Ltd | $23.05 | -1.16% | $31.6B | — |
| 000661.SZChangchun High-Tech Industries (Group) Inc. | $70.62 | -1.51% | $28.8B | — |
| 000999.SZChina Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | $23.75 | -1.53% | $39.5B | — |
| 002252.SZShanghai RAAS Blood Products Co., Ltd. | $4.81 | -2.04% | $31.7B | — |
| 300759.SZPharmaron Beijing Co., Ltd. |
| $43.09 |
| +1.72% |
| $63.7B |
| — |
| 300832.SZShenzhen New Industries Biomedical Engineering Co., Ltd. | $48.91 | -0.08% | $38.4B | — |
| 300896.SZImeik Technology Development Co.,Ltd. | $88.06 | -0.32% | $26.6B | — |
Source: Financial Modeling Prep · peers by sector/industry